Header Logo

Connection

LAVINIA P MIDDLETON to Aged

Back to Details
This is a "connection" page, showing publications LAVINIA P MIDDLETON has written about Aged.
LAVINIA P MIDDLETON
Connection Strength
0.218
Aged
  1. Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ. Arch Pathol Lab Med. 2011 Jun; 135(6):737-43.
    View in: PubMed
    Score: 0.017
  2. Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion. Histopathology. 2008 Nov; 53(5):545-53.
    View in: PubMed
    Score: 0.014
  3. Expression of ERalpha and ERbeta in lobular carcinoma in situ. Histopathology. 2007 Jun; 50(7):875-80.
    View in: PubMed
    Score: 0.013
  4. Expression analysis of cystatin C and M in laser-capture microdissectioned human breast cancer cells--a preliminary study. Pathol Res Pract. 2005; 200(11-12):753-62.
    View in: PubMed
    Score: 0.011
  5. Myolipoma of the breast: mammographic, sonographic, and pathologic correlation. Breast J. 2004 May-Jun; 10(3):259-60.
    View in: PubMed
    Score: 0.010
  6. Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy. Mod Pathol. 2004 Feb; 17(2):165-71.
    View in: PubMed
    Score: 0.010
  7. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol. 2003 Feb; 16(2):120-9.
    View in: PubMed
    Score: 0.009
  8. E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast. Ann Diagn Pathol. 2002 06; 6(3):141-7.
    View in: PubMed
    Score: 0.009
  9. Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer. 2002 Apr 01; 94(7):1910-6.
    View in: PubMed
    Score: 0.009
  10. Axillary Nodal Metastases in Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma: Comparison of Node Detection and Morphology by Ultrasound. AJR Am J Roentgenol. 2022 01; 218(1):33-41.
    View in: PubMed
    Score: 0.008
  11. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol. 2000 Dec; 24(12):1650-6.
    View in: PubMed
    Score: 0.008
  12. The histological spectrum of hemangiopericytoma: application of immunohistochemical analysis including proliferative markers to facilitate diagnosis and predict prognosis. Hum Pathol. 1998 Jun; 29(6):636-40.
    View in: PubMed
    Score: 0.007
  13. Imaging of Intracystic Papillary Carcinoma. Curr Probl Diagn Radiol. 2019 Jul - Aug; 48(4):348-352.
    View in: PubMed
    Score: 0.007
  14. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program. Ann Oncol. 2018 02 01; 29(2):405-417.
    View in: PubMed
    Score: 0.007
  15. A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer. Int J Radiat Oncol Biol Phys. 2017 11 15; 99(4):777-783.
    View in: PubMed
    Score: 0.006
  16. Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision. Clin Breast Cancer. 2013 Dec; 13(6):439-49.
    View in: PubMed
    Score: 0.005
  17. Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancer. Cancer. 2012 Mar 15; 118(6):1507-14.
    View in: PubMed
    Score: 0.004
  18. Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol. 2011 Aug; 42(8):1169-77.
    View in: PubMed
    Score: 0.004
  19. Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapy. Cancer Invest. 2010 Jun; 28(5):554-9.
    View in: PubMed
    Score: 0.004
  20. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer. Cancer. 2009 Apr 15; 115(8):1605-12.
    View in: PubMed
    Score: 0.004
  21. Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer. Am J Surg. 2009 Sep; 198(3):387-91.
    View in: PubMed
    Score: 0.004
  22. Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation. Ann Surg Oncol. 2009 Jun; 16(6):1606-11.
    View in: PubMed
    Score: 0.004
  23. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer. 2009 Mar 01; 115(5):962-71.
    View in: PubMed
    Score: 0.004
  24. Primary breast cancer in men: clinical, imaging, and pathologic findings in 57 patients. AJR Am J Roentgenol. 2008 Dec; 191(6):1631-9.
    View in: PubMed
    Score: 0.003
  25. Loss of myoepithelium is variable in solid papillary carcinoma of the breast. Histopathology. 2007 Nov; 51(5):657-65.
    View in: PubMed
    Score: 0.003
  26. Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast. Am J Surg. 2007 Oct; 194(4):450-5.
    View in: PubMed
    Score: 0.003
  27. African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy. Cancer. 2006 Dec 01; 107(11):2662-8.
    View in: PubMed
    Score: 0.003
  28. Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors. J Clin Oncol. 2006 Mar 01; 24(7):1037-44.
    View in: PubMed
    Score: 0.003
  29. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg. 2006 Feb; 243(2):257-64.
    View in: PubMed
    Score: 0.003
  30. Adjuvant systemic therapy for male breast carcinoma. Cancer. 2005 Dec 01; 104(11):2359-64.
    View in: PubMed
    Score: 0.003
  31. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer. 2005 Apr 15; 103(8):1581-6.
    View in: PubMed
    Score: 0.003
  32. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Am J Surg Pathol. 2004 Dec; 28(12):1646-51.
    View in: PubMed
    Score: 0.003
  33. Intracystic papillary carcinoma of the breast with invasion. AJR Am J Roentgenol. 2004 Nov; 183(5):1516.
    View in: PubMed
    Score: 0.003
  34. Role of sonography in diagnosing and staging invasive lobular carcinoma. J Clin Ultrasound. 2004 Sep; 32(7):323-32.
    View in: PubMed
    Score: 0.003
  35. Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1074-9.
    View in: PubMed
    Score: 0.003
  36. Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg. 2002 Oct; 184(4):364-8.
    View in: PubMed
    Score: 0.002
  37. Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma. Cancer. 2002 Jun 15; 94(12):3107-14.
    View in: PubMed
    Score: 0.002
  38. Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol. 2002 Mar; 26(3):377-82.
    View in: PubMed
    Score: 0.002
  39. Allelic loss on chromosome 22q in epithelioid sarcomas. Hum Pathol. 1998 Jun; 29(6):604-8.
    View in: PubMed
    Score: 0.002
  40. Molecular genetics of amyloid neuropathy in Europe. Lancet. 1989 Mar 11; 1(8637):524-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.